AB0737 Aminaphtone increases skin blood perfusion and improves clinical symptoms in patients with raynaud’s phenomenon independently from different treatment backgrounds

Abstract

BackgroundAminaphtone is a vasoactive drug that was recently demonstrated to improve both peripheral blood perfusion (BP) and clinical symptoms of Raynaud’s phenomenon (RP) in patients with either primary or secondary...